DAO and attention deficit-hyperactivity disorder: A third drug, lisdexamfetamine dimesylate, an amphetamine approved for the treatment of ADHD, promoted a strong upregulation of DAO mRNA levels, suggesting that this drug may induce DAO activity [116], thus helping to decrease blood histamine levels.